The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $34.08 in the prior trading day, Zai Lab Limited ADR (NASDAQ: ZLAB) closed at $32.73, down -3.96%. In other words, the price has decreased by -$3.96 from its previous closing price. On the day, 1.02 million shares were traded. ZLAB stock price reached its highest trading level at $33.53 during the session, while it also had its lowest trading level at $32.305.
Ratios:
Our goal is to gain a better understanding of ZLAB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.09 and its Current Ratio is at 3.26. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 07, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $55.
On March 03, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $29 to $36.10.
On December 14, 2023, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $47.50.Morgan Stanley initiated its Overweight rating on December 14, 2023, with a $47.50 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 02 ’25 when Du Ying sold 7,072 shares for $35.23 per share. The transaction valued at 249,147 led to the insider holds 536,962 shares of the business.
Du Ying bought 7,072 shares of ZLAB for $249,144 on Jul 02 ’25. On Jun 30 ’25, another insider, Du Ying, who serves as the Chairperson & CEO of the company, sold 6,918 shares for $35.52 each. As a result, the insider received 245,727 and left with 526,034 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 3684416000 and an Enterprise Value of 37368528896. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.65 while its Price-to-Book (P/B) ratio in mrq is 4.38. Its current Enterprise Value per Revenue stands at 89.329 whereas that against EBITDA is -146.075.
Stock Price History:
The Beta on a monthly basis for ZLAB is 1.03, which has changed by 0.8183334 over the last 52 weeks, in comparison to a change of 0.1116153 over the same period for the S&P500. Over the past 52 weeks, ZLAB has reached a high of $44.34, while it has fallen to a 52-week low of $16.01. The 50-Day Moving Average of the stock is -3.38%, while the 200-Day Moving Average is calculated to be 7.78%.
Shares Statistics:
The stock has traded on average 1.00M shares per day over the past 3-months and 628830 shares per day over the last 10 days, according to various share statistics. A total of 110.59M shares are outstanding, with a floating share count of 109.14M. Insiders hold about 1.31% of the company’s shares, while institutions hold 50.55% stake in the company. Shares short for ZLAB as of 1749772800 were 4388732 with a Short Ratio of 4.04, compared to 1747267200 on 4975515. Therefore, it implies a Short% of Shares Outstanding of 4388732 and a Short% of Float of 4.5500003.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
